0
0
1/4/23 at 7:32pm
Organization
Targetedonc.com
Author
Nichole Tucker
32 words
0
Comments
New results from the advanced pancreatic cancer cohort of the CodeBreaK 100 trial show positive efficacy and safety.
You are the first to view
https://www.targetedonc.com/view/sotorasib-reveals-anti-tumor-efficacy-in-kras-g12c-positive-advanced-pancreatic-cancer
Create an account
or login to join the discussion